Trump’s tariffs could strain medicine supply and drive drug costs
The last few days have been a rollercoaster for the pharmaceutical industry. Mexico and Canada were bracing themselves for the …
Post
-
-
Driving innovation in respiratory health: Areteia’s 2025 milestones and future goals
During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a detailed review of …
-
MedPharm appoints Bill Humphries as new CEO
MedPharm has appointed Bill Humphries as its new CEO, marking a significant step in the company's strategic growth. The move follows …
-
Jabil acquires CDMO Pii to support drug development customers
Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer support for drug development customers. The acquisition …
-
Radiopharmaceutical deals drive sector growth despite supply crisis
A reinvigorated interest in radiopharmaceuticals has brought nuclear medicine to the foreground with deals over 2024 further exemplifying this trend. As …
-
Italian charity seeks EMA approval for rescued gene therapy
Italian research charity Telethon Foundation is one step closer to getting a gene therapy to treat rare disease Wiskott-Aldrich syndrome …
-
Thermo Fisher continues viral vector withdrawal; lays off 300 employees
Thermo Fisher is cutting the headcount at two of its US facilities by 300 as the company continues to overhaul …
-
USC receives grant for gene therapy targeting glioblastoma
The University of Southern California (USC) has received a $6m grant from the California Institute for Regenerative Medicine (CIRM) to …
-
Immunotherapeutic responses and their assessments
Immunotherapeutics have transformed the landscape of cancer outcomes. It is crucial that the atypical response patterns seen with them are …
-
World Cancer Day: WHO warns of rising cancer burden in Southeast Asia
The World Health Organization (WHO) has reported a significant increase in cancer cases across the Southeast Asia region, projecting an …
-
Vanda and AnaptysBio link for generalised pustular psoriasis therapy
Vanda Pharmaceuticals and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise the fully humanised immunoglobulin G4 …
-
Microplastics: the silent threat
Microplastics, tiny plastic bits less than five millimetres in size, come from breaking down larger plastics and are now everywhere. …
-
AstraZeneca lung cancer therapy Imfinzi recommended for EU approval
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended AstraZeneca's Imfinzi (durvalumab) for approval in the …
-
People-focused cancer care demands policy support
Access to high-quality cancer care remains deeply uneven worldwide. While advances in cancer treatment and diagnostics are improving survival rates …
-
AdvanCell raises $112m as radiopharma buzz continues
AdvanCell, an Australia-based radiopharmaceutical company, has raised $112m as investor interest in the radiopharma sector continues in 2025. The funding round …
